Total Payments
$8,209
2024 Payments
$1,836
Companies
15
Transactions
159
Medicare Patients
810
Medicare Billing
$87,964
Payment Breakdown by Category
Food & Beverage$5,312 (64.7%)
Travel$2,897 (35.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,312 | 144 | 64.7% |
| Travel and Lodging | $2,897 | 15 | 35.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $2,976 | 47 | $0 (2024) |
| Abbott Laboratories | $2,970 | 37 | $0 (2024) |
| Boston Scientific Corporation | $712.15 | 10 | $0 (2024) |
| ABBVIE INC. | $414.71 | 15 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $320.82 | 20 | $0 (2024) |
| Vertos Medical, Inc. | $232.30 | 3 | $0 (2024) |
| PFIZER INC. | $144.25 | 8 | $0 (2024) |
| Axonics, Inc. | $139.69 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $92.05 | 5 | $0 (2024) |
| Averitas Pharma Inc. | $84.19 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,836 | 59 | Boston Scientific Corporation ($344.28) |
| 2023 | $3,563 | 62 | Medtronic, Inc. ($2,664) |
| 2022 | $2,811 | 38 | Abbott Laboratories ($2,747) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Urology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Gastroenterology | ||||||
| 11/12/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.27 | General |
| Category: Opioid Analgesic | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: Gastroenterology | ||||||
| 10/24/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $14.18 | General |
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.80 | General |
| Category: Opioid Analgesic | ||||||
| 10/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: PAIN | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: PAIN | ||||||
| 09/30/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $11.74 | General |
| Category: Opioid Analgesic | ||||||
| 09/19/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $13.24 | General |
| Category: Opioid Analgesic | ||||||
| 09/11/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $106.64 | General |
| Category: Urology | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 08/29/2024 | ConvaTec Inc. | AQUACEL AG+ EXTRA (Device) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: ADVANCED WOUND CARE | ||||||
| 08/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Gastroenterology | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $10.79 | General |
| Category: Opioid Analgesic | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Gastroenterology | ||||||
| 08/06/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Opioid Analgesic | ||||||
| 07/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.11 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.28 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 347 | 553 | $134,613 | $38,161 |
| 2022 | 7 | 463 | 611 | $269,112 | $49,803 |
Total Patients
810
Total Services
1,164
Medicare Billing
$87,964
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 176 | $49,187 | $13,052 | 26.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 200 | $38,289 | $10,842 | 28.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 87 | 124 | $25,403 | $7,189 | 28.3% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 35 | 37 | $16,200 | $5,395 | 33.3% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 14 | 16 | $5,534 | $1,682 | 30.4% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 87 | 104 | $104,000 | $15,960 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 172 | 250 | $99,103 | $14,398 | 14.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 124 | 161 | $33,837 | $9,805 | 29.0% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2022 | 39 | 55 | $17,600 | $6,168 | 35.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $6,053 | $1,229 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $5,280 | $1,174 | 22.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $3,240 | $1,069 | 33.0% |
About Paul Siegwald, PA
Paul Siegwald, PA is a Physician Assistant healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2021. The National Provider Identifier (NPI) number assigned to this provider is 1346909694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul Siegwald, PA has received a total of $8,209 in payments from pharmaceutical and medical device companies, with $1,836 received in 2024. These payments were reported across 159 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($5,312).
As a Medicare-enrolled provider, Siegwald has provided services to 810 Medicare beneficiaries, totaling 1,164 services with total Medicare billing of $87,964. Data is available for 2 years (2022–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant
- Location Cincinnati, OH
- Active Since 12/14/2021
- Last Updated 12/03/2024
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1346909694
Products in Payments
- PROCLAIM (Device) $2,494
- SYNCHROMEDII (Device) $2,104
- INTELLIS ADAPTIVESTIM (Device) $834.70
- AXIUM (Device) $337.07
- UBRELVY (Drug) $267.13
- mild Device Kit (Device) $232.30
- Spectra WaveWriter (Device) $198.13
- Belbuca (Drug) $191.52
- QULIPTA (Drug) $147.58
- NURTEC ODT (Drug) $144.25
- Axonics (Device) $139.69
- XTAMPZA (Drug) $129.30
- OCTRODE (Device) $97.09
- RELISTOR (Drug) $92.05
- QUTENZA (Drug) $84.19
- WaveWriter Alpha Prime 16 (Device) $61.63
- Prialt (Drug) $56.77
- EXCLAIM (Device) $42.68
- ACTIVOS 10 BONE CEMENT (Device) $25.65
- AQUACEL AG+ EXTRA (Device) $17.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Cincinnati
Mr. Steven Wurzelbacher, Pa-C, PA-C
Physician Assistant — Payments: $242,800
Physician Assistant $242,800
Mrs. Melissa Dove, Pa-C, PA-C
Physician Assistant — Payments: $39,299
Physician Assistant $39,299
Sarah Burkart, Pa, PA
Physician Assistant — Payments: $7,503
Physician Assistant $7,503
Ms. Julie Bruns, P.a.-C, P.A.-C
Physician Assistant — Payments: $5,026
Physician Assistant $5,026
Mr. Cory Clark, Pa, PA
Physician Assistant — Payments: $4,826
Physician Assistant $4,826
Lanaya Hils, Pa-C, PA-C
Physician Assistant — Payments: $4,785
Physician Assistant $4,785